欧盟法规
REACH注册ECHA物质C&L通报REACH预注册上下游产品
CAS号98-09-9 苯磺酰氯 | CAS号5339-67-3 N-Ethyl benzene... | CAS号16066-31-2 苯基亚磺酰胺 | CAS号938-10-3 N-diazobenzenes... | CAS号2512-24-5 N-叔丁基苯磺酰胺 | CAS号5339-69-5 N-异丙基苯磺酰胺(IBSA) | CAS号129716-35-4 N-cyclopropyl b... | CAS号117824-61-0 N-(3-Phenylprop... | CAS号5183-78-8 N-甲基苯磺酰胺 | CAS号1709-50-8 N,N-二乙基苯磺酰胺 | CAS号107786-78-7 cyclopentyl N-[... | CAS号10504-97-9 N-[(4-chlorophe... | CAS号837-18-3 N-苄基苯磺酰胺 | CAS号108223-53-6 Benzenesulfonam... | CAS号111711-98-9 [1-(benzenesulf... | CAS号107920-79-6 4-苯磺酰氨基苯甲酸甲酯 | CAS号104997-09-3 N-(3-氨基苯基)苯磺酰胺 | CAS号104667-72-3 Benzenesulfonam... | CAS号1056-25-3 N-(triphenyl-λ5... | CAS号4392-37-4 N-(氨基亚氨基甲基)苯磺胺合成工艺路线路线简述
- 合成目标产物 Benzenesulfonamide 主要起始原料 Benzenesulfonyl Chloride
- 58-33-3 + 16917-09-2 = 98-10-2 + 7640-51-9
反应条件:1.1 Reagents: Perchloric Acid Solvents: Water; 24 H,303 K
标题:Comparative Study On The Oxidation Kinetics Of Structural Isomers By Acidified N-Bromo-Benzenesulfonamide: A Mechanistic Determination
作者:Viswanathan,Sushma Nurani; Pranesh,Shubha Jayachamarajapura; Swamy,Puttaswamy
参考文献:Chemistry Africa 日期:2019 卷标:2(3) 页码:435-441
二氯胺b置于potassium Thioacyanate体系中,用 甲醇,水 作为反应溶剂,化学反应生成 苯磺酰胺
参考文献:Gowda,B. Thimme; Bhat,J. Ishwara,Journal Of The Indian Chemical Society,1988,Vol. 65,P. 512-515
标题:Gowda,B. Thimme; Bhat,J. Ishwara,Journal Of The Indian Chemical Society,1988,Vol. 65,P. 512-515
专利信息
专利号:US-11661406-B2
优先权日:2018-08-13
标 题 :Method for producing intermediate useful for synthesis of SGLT inhibitor
发明人:LI QING RI; YOON HEE KYOON
权利人:DAEWOONG PHARMACEUTICAL CO LTD
摘要:A method of preparing an intermediate useful for the synthesis of a diphenylmethane derivative that can be used as an SGLT inhibitor is described. A method of synthesizing a compound of Formula 7 can address problems of existing synthesis processes requiring the synthesis of the Grignard reagent and management of related substances. In addition, the method can minimize the generation of related substances, and thus does not require reprocessing of reaction products, thereby simplifying the process. Accordingly, the production yield of a diphenylmethane derivative can be maximized.
专利号:US-11548898-B2
优先权日:2017-07-06
标题 :Synthesis of halichondrins
发明人:KISHI YOSHITO; AI YANRAN; YE NING; WANG QIAOYI; YAHATA KENZO; ISO Kentaro; NAINI SANTHOSH REDDY; YAMASHITA SHUJI; LEE JIHOON; OHASHI ISAO; FUKUYAMA TAKASHI
权利人:HARVARD COLLEGE; EISAI R&D MAN CO LTD
摘要:The present invention provides methods for the synthesis of ketones involving a Ni/Zr-mediated coupling reaction. The Ni/Zr-mediated ketolization reactions can be used in the synthesis of halichondrins (e.g., halichondrin A, B, C; homohalichondrin A, B, C; norhalichondrin A, B, C), and analogs thereof. Therefore, the present invention also provides synthetic methods useful for the synthesis of halichondrins, and analogs thereof. Also provided herein are compounds (i.e., intermediates) useful in the synthesis of halichondrins, and analogs thereof. In particular, the present invention provides methods and compounds useful in the synthesis of compound of Formula (H3-A).
专利号:US-9353057-B2
优先权日:2003-12-30
标 题:Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
发明人:GALLOP MARK A; DAI XUEDONG; SCHEUERMAN RANDALL A; RAILLARD STEPHEN P; MANTHATI SURESH K; YAO FENMEI; PHAN THU; LUDWIKOW MARIA; PENG GE; BHAT SEEMA
权利人:XENOPORT INC
摘要:Methods for synthesis of 1-(acyloxy)-alkyl carbamates, particularly, the synthesis of 1-(acyloxy)-alkyl carbamate prodrugs of primary or secondary amine-containing drugs are described. Also described are methods for synthesis of 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonates which are useful intermediates in the synthesis of 1-(acyloxy)-alkyl carbamates are also described.
专利号:US-2006287520-A1
优先权日:2005-05-16
标 题 :Synthesis of salinosporamide A and analogues thereof
发明人:DANISHEFSKY SAMUEL J; ENDO ATSUSHI
权利人:DANISHEFSKY SAMUEL J; ENDO ATSUSHI
摘要:A novel synthesis of salinosporamide A is provided. Salinospoamide A as well as structurally related natural products, omuralide and lactacystin, have been shown to be proteasome inhibitors. Therefore, these compounds as well as analogues of these natural products may be useful in the treatment of proliferative diseases such as cancer, autoimmune diseases, diabetic retinopathy, etc. The invention provides for the synthesis of salinosporamide A as well as analogs thereof using a convenient point for derivatization of the bicyclic core. Pharmaceutical compositions and method of using the inventive compounds are also provided.
专利号:US-7910623-B2
优先权日:2005-07-22
标 题 :Synthesis of scabronines and analogues thereof
发明人:DANISHEFSKY SAMUEL J; WATERS STEPHEN P
权利人:SLOAN KETTERING INST CANCER
摘要:A novel synthesis of scabronines, which are related to a broader class of angularly fused tricyclic diterpenoids known as cyathanes, is provided. Scabronine G, its methyl ester derivative, and other analogs have been shown to have neurotrophic activity. Therefore, these compounds are particularly useful in treating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Huntington's diseases, etc. The invention provides for the synthesis of scabronines as well as analogs thereof. Pharmaceutical compositions and method of using the inventive compounds are also provided.
专利号:WO-2012047907-A9
优先权日:2010-10-04
标题 :Synthesis of c5-substituted tetracyclines, uses thereof, and intermediates thereto
发明人:MYERS ANDREW G; WRIGHT PETER M; HECKER EVAN
权利人:HARVARD COLLEGE; MYERS ANDREW G; WRIGHT PETER M; HECKER EVAN
摘要:The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics. The recent development of a modular synthesis of tetracycline analogs through a chiral enone intermediate has allowed for the efficient synthesis of novel tetracycline analogs never prepared before. The present invention provides more efficient routes for preparing the enone intermediate and allows for a wide variety of substituents at position 5 of the tetracycline ring system.